Corbus Pharmaceuticals Holdings, Inc (CRBP) Covered Calls

You can sell covered calls on Corbus Pharmaceuticals Holdings, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CRBP (prices last updated Fri 4:16 PM ET):

Corbus Pharmaceuticals Holdings, Inc (CRBP) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
7.08 -0.22 7.10 7.14 1.1M -7.9 0.5B
Covered Calls For Corbus Pharmaceuticals Holdings, Inc (CRBP)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Jun 21 7.5 0.35 6.79 5.2% 52.7%
Jul 19 7.5 0.50 6.64 7.5% 42.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of various therapeutic products to treat inflammatory and fibrotic diseases. The company's lead product candidate is lenabasum, a synthetic oral endocannabinoid-mimetic drug that is in Phase III clinical trials for the treatment of systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus diseases. Corbus Pharmaceuticals Holdings, Inc. was founded in 2009 and is based in Norwood, Massachusetts.